Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

A randomized clinical trial of the impact of local estrogen on postoperative tissue quality after vaginal reconstructive surgery.

Karp DR, Jean-Michel M, Johnston Y, Suciu G, Aguilar VC, Davila GW.

Female Pelvic Med Reconstr Surg. 2012 Jul-Aug;18(4):211-5. doi: 10.1097/SPV.0b013e31825e6401.

PMID:
22777369
2.

Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.

Weisberg E, Ayton R, Darling G, Farrell E, Murkies A, O'Neill S, Kirkegard Y, Fraser IS.

Climacteric. 2005 Mar;8(1):83-92.

PMID:
15804736
3.

Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women.

Pinkerton JV, Shifren JL, La Valleur J, Rosen A, Roesinger M, Siddhanti S.

Menopause. 2003 Jan-Feb;10(1):45-52.

PMID:
12544676
5.

The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.

Gupta P, Ozel B, Stanczyk FZ, Felix JC, Mishell DR Jr.

Menopause. 2008 Jan-Feb;15(1):94-7.

PMID:
17882008
6.

Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.

Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M.

Obstet Gynecol. 2008 Jan;111(1):67-76. doi: 10.1097/01.AOG.0000296714.12226.0f.

PMID:
18165394
7.

Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial.

Melisko ME, Goldman ME, Hwang J, De Luca A, Fang S, Esserman LJ, Chien AJ, Park JW, Rugo HS.

JAMA Oncol. 2017 Mar 1;3(3):313-319. doi: 10.1001/jamaoncol.2016.3904.

PMID:
27832260
8.
9.

A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.

Kagan R, Williams RS, Pan K, Mirkin S, Pickar JH.

Menopause. 2010 Mar;17(2):281-9. doi: 10.1097/GME.0b013e3181b7c65f.

PMID:
19779382
11.

Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.

Simon J, Nachtigall L, Gut R, Lang E, Archer DF, Utian W.

Obstet Gynecol. 2008 Nov;112(5):1053-60. doi: 10.1097/AOG.0b013e31818aa7c3. Erratum in: Obstet Gynecol. 2008 Dec;112(6):1392.

PMID:
18978105
12.

A multicentre Australian trial of low dose estradiol therapy for symptoms of vaginal atrophy using a vaginal ring as delivery system.

Fraser IS, Ayton R, Farrell E, Weisberg E, Darling G, Murkies A.

Maturitas. 1995 Dec;22 Suppl:S41. No abstract available.

PMID:
8775776
13.
15.

Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.

Barentsen R, van de Weijer PH, Schram JH.

Eur J Obstet Gynecol Reprod Biol. 1997 Jan;71(1):73-80.

PMID:
9031963
16.

A prospective randomized comparative study of the effects of intranasal and transdermal 17 beta-estradiol on postmenopausal symptoms and vaginal cytology.

Odabaşi AR, Yüksel H, Demircan SS, Kaçar DF, Culhaci N, Ozkara EE.

J Postgrad Med. 2007 Oct-Dec;53(4):221-7.

17.

Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis.

Marx P, Schade G, Wilbourn S, Blank S, Moyer DL, Nett R.

Maturitas. 2004 Jan 20;47(1):47-54.

PMID:
14706765
18.

Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study.

Eriksen PS, Rasmussen H.

Eur J Obstet Gynecol Reprod Biol. 1992 Apr 21;44(2):137-44.

PMID:
1587379
19.

Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.

Crandall C.

J Womens Health (Larchmt). 2002 Dec;11(10):857-77. Review.

PMID:
12626086
20.

Histologic and cytologic effects of vaginal estrogen in women with pelvic organ prolapse: a randomized controlled trial.

Vaccaro CM, Mutema GK, Fellner AN, Crisp CC, Estanol MV, Kleeman SD, Pauls RN.

Female Pelvic Med Reconstr Surg. 2013 Jan-Feb;19(1):34-9. doi: 10.1097/SPV.0b013e318278cc40.

PMID:
23321657

Supplemental Content

Support Center